ADVITOS presented the latest generation of its innovative ADVOS system, the ADVOS BK300, at this year’s DIVI Congress (Congress of the German Interdisciplinary Association for Intensive Care and Emergency Medicine) in Hamburg. Under the motto “Next Level Blood Purification”, the company is taking extracorporeal blood purification to a completely new level and is setting another milestone in intensive care medicine with the newly integrated renal replacement therapy mode (ADVOS RRT).

“Next Level Blood Purification” – The future of multi-organ support
The ADVOS BK300 was developed to significantly improve treatment options for patients with multiple organ failure. The new renal replacement therapy (RRT) function enables patient-specific clearance, allowing patients with acute or chronic kidney failure in intensive care units to be treated even more efficiently.

“With the ADVOS BK300, we are realizing our vision of ‘Next Level Blood Purification’,” explains Dr. Claus Jessen, Managing Director of ADVITOS GmbH. “The combination of unique multi-organ therapy and the new RRT mode offers intensive care physicians a single, flexible, powerful tool that can permanently change the care of critically ill patients.”

A highlight at the DIVI Congress
The ADVOS BK300 was presented as a groundbreaking solution for intensive care medicine at the DIVI Congress 2024 in the CCH (Congress Center Hamburg). In an exclusive product launch event, the main functionalities of the new system were presented to the specialist audience.
Visitors were able to experience the device in live demonstrations at the trade fair stand and see its versatility for themselves. In particular, the integration of renal replacement therapy into an already multifunctional platform was praised by experts as groundbreaking.

A new chapter in user-friendliness
In addition to its medical innovation, the ADVOS BK300 impresses with its intuitive operation and user-friendly design, which both significantly reduces the workload of medical staff and simplifies and fulfills the processes in intensive care units.